Objective To evaluate experience for early diagnosis of pulmonary tembolism alter thoracic injury or surgery. Methods The 9 patients after thoracic injury or surgery with highly-suspected pulmonary embolism underwent chest radiograph of X-ray, helical CT pulmonary angiography, electrocardiogram, radionuclide pulmonary ventilation perfusion imaging, D dimer assay and arterial blood gas analysis respectively and the clinic data and results were analyzed. Results All patients were diagnosed and recovered after 8 patients received thrombolytic therapy and another patient received anticoagulant therapy. Conclusion If there were some symptoms such as suddenly severe dyspnea, cyanosis, with/without chest pains and the feeling of fear to death unable to be explained by original disease on those patients alter thoracic injury or surgery, it's very important for pulmonary embolism to be recognized, and early diagnosis and quickly efficient treatment is the key to prevent death. Helical CT pulmonary angiography is a safe, cheap, noninvasive and effective method for the diagnosis of pulmonary embolism with high sensitivity and specificity.

Objective To investigate the effect of neoadjuvent chomotherapy of paclitexel plus eisplatin for improving the surgical resection rate of stage ⅢA non-small cell lung cancer(NSCLC).Methods 46 patients with stage ⅢA NSCLC were randomly divided into neoadjuvant chemotherapy group(25 caeses) and simple operative group(25 cases).Neoedjuvant chemotherapy group(NCG) received two-cycle chemotherapy and then underwent operation.Simple operative group(SOG) was only treated by operation.Results The operative resection rate of NCG was 99.0%,radical resection rate was 64.0%.It was higher obviously than that simple operative group(SOG)(P

Objective To study the long-term results of 90 cases with inoperable stage Ⅲ non-small cell lung cancer.Methods All patients received CAP regimen or MVP regimen chemotherapy.80 patients received radiotherapy.Results The results showed that 1-,3-,5-year survival rates were 53.4%,19.5% and 8.5% respectively.The 3-,5-year survival rate for squamous cell carcinoma were higher than those adenocarcinoma(P